Pharming Group N.V. (PHARM.AS)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

2Y 5Y 10Y All
Quarterly Annual TTM

Revenue Annual

0 150M 300M 450M FY20: 212.2M FY21: 198.9M FY22: 205.6M FY23: 245.3M FY24: 297.2M FY25: 376.1M FY20 FY21 FY22 FY23 FY24 FY25

Gross Profit Annual

0 150M 300M 450M FY20: 188.6M FY21: 177.7M FY22: 188.1M FY23: 220.1M FY24: 261.8M FY25: 330.6M FY20 FY21 FY22 FY23 FY24 FY25

Operating Income Annual

-30M 0 30M 60M 90M FY20: 76.3M FY21: 13.6M FY22: 18.2M FY23: -5.4M FY24: -8.6M FY25: 25.8M FY20 FY21 FY22 FY23 FY24 FY25

Net Income Annual

-15M 0 15M 30M 45M FY20: 37.7M FY21: 16M FY22: 13.7M FY23: -10.5M FY24: -11.8M FY25: 2.5M FY20 FY21 FY22 FY23 FY24 FY25

Cost of Revenue Annual

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Cash Flow Annual

-30M 0 30M 60M 90M FY20: 83.6M FY21: 37.8M FY22: 22.5M FY23: -17.3M FY24: -1.8M FY25: 54.7M FY20 FY21 FY22 FY23 FY24 FY25

Free Cash Flow Annual

-30M 0 30M 60M 90M FY20: 79M FY21: 27.1M FY22: 21.1M FY23: -18.7M FY24: -2.6M FY25: 54M FY20 FY21 FY22 FY23 FY24 FY25

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

EPS TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.